Following a slump in new deals during the early months of the COVID-19 pandemic, mergers and acquisitions are showing renewed signs of life.
In the biggest healthcare acquisition to date in 2020, Siemens Healthineers AG (FRA: SHL) will buy Varian Medical Systems, Inc. (NYSE: VAR) for 15.2 billion euros (AU$25 billion).
As first reported by Bloomberg, the acquisition will be financed via a bridge loan from parent company Siemens AG. (Now that's a nice parental loan!) Healthineers offered $177.5 per share. That was 24% above Varian's closing price on Friday of US$142.72.
Siemens will not participate in a capital raising that Healthineers has planned for later this year. But the company reported its ownership of the Healthineers branch is expected to drop from 85% to 72%.
The acquisition is expected to benefit both companies. As Bloomberg notes, they "have collaborated for more than a decade in areas such as radiotherapy diagnostics for cancer treatments."
A snapshot of Siemens Healthineers and Varian Medical Systems
Based in Erlangen, Germany, Siemens Healthineers is a medical technology company with a market cap of $43.3 billion. In March 2020, it reported quarterly revenues of $3.7 billion, up 5.1% year-on-year. Net profits were up 4.0%.
At time of writing, in early morning trade on the German stock exchange, the share price is up 3.1% on the news. After following most shares lower in late February and into March, the share is up 6.0% year-to-date.
As for the new acquisition…
Varian Medical Systems designs and makes radiation oncology treatments and software. The company is based in Palo Alto, California in the United States. Year-to-date, prior to the acquisition, the Varian share price was down 1.4%.
With Varian under its wing, Siemens Healthineers is an international share you may want to look into more closely for your long-term portfolio. And it's another good reminder of why Australian investors should look beyond the ASX for quality shares to help diversify their portfolios.
